Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
TCDA Tricida, Inc. monthly Stock Chart
TCDA [NASD]
Tricida, Inc.
Healthcare | Drugs - Generic | USA
statements
Index- P/E- EPS (ttm)-3.71 Insider Own2.10% Shs Outstand50.89M Perf Week23.83%
Market Cap1.36B Forward P/E- EPS next Y-3.63 Insider Trans-79.34% Shs Float48.40M Perf Month-4.42%
Income-176.80M PEG- EPS next Q-1.39 Inst Own- Short Float7.05% Perf Quarter-27.48%
Sales- P/S- EPS this Y-53.40% Inst Trans0.12% Short Ratio12.36 Perf Half Y-9.43%
Book/sh5.32 P/B5.04 EPS next Y29.50% ROA-50.80% Target Price52.50 Perf Year-21.38%
Cash/sh6.05 P/C4.43 EPS next 5Y- ROE-65.30% 52W Range18.02 - 44.30 Perf YTD-28.96%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-39.48% Beta-
Dividend %- Quick Ratio7.90 Sales past 5Y- Gross Margin- 52W Low48.74% ATR2.29
Employees119 Current Ratio7.90 Sales Q/Q- Oper. Margin- RSI (14)53.92 Volatility8.47% 10.67%
OptionableYes Debt/Eq0.00 EPS Q/Q-92.60% Profit Margin- Rel Volume0.62 Prev Close25.35
ShortableYes LT Debt/Eq0.22 EarningsFeb 27 AMC Payout- Avg Volume276.00K Price26.81
Recom2.20 SMA2019.17% SMA50-10.39% SMA200-21.22% Volume172,054 Change5.76%
Jun-27-19Initiated Goldman Buy $48
May-24-19Initiated Needham Buy $50
Jul-23-18Initiated JP Morgan Neutral $34
Jul-23-18Initiated Goldman Neutral $32
Apr-09-20 11:43AM  Tricida to Present at the Needham Virtual Healthcare Conference Business Wire +5.76%
Apr-07-20 08:03PM  Hedge Funds Have Never Been This Bullish On Tricida, Inc. (TCDA) Insider Monkey
Mar-24-20 08:30AM  Tricida Announces Multiple Data Presentations on Veverimer and Metabolic Acidosis to Be Given at the Virtual National Kidney Foundation 2020 Spring Clinical Meetings Business Wire +5.07%
Mar-13-20 01:56PM  Trade Alert: The CFO & Executive VP Of Tricida, Inc. (NASDAQ:TCDA), Geoffrey Parker, Has Just Spent US$147k Buying Shares Simply Wall St.
Mar-12-20 09:00AM  Tricida Supports the National Kidney Foundation in Asking "Are You the 33%?" Business Wire -9.27%
Mar-09-20 08:30AM  Tricida Hires Robert McKague as Executive Vice President, General Counsel & Chief Compliance Officer Business Wire
Feb-24-20 04:15PM  Tricida to Present at the Cowen 40th Annual Health Care Conference Business Wire
Feb-19-20 10:00AM  Tricida to Report Fourth Quarter and Year End 2019 Financial Results and Host Conference Call and Webcast on Thursday, February 27, 2020 Business Wire
Jan-07-20 01:59PM  Tricida to Present at the 38th Annual J. P. Morgan Healthcare Conference Business Wire
Dec-24-19 11:55AM  Did Tricida, Inc. (NASDAQ:TCDA) Insiders Buy Up More Shares? Simply Wall St.
Dec-11-19 02:30PM  Hedge Funds Have Never Been More Bullish On Tricida, Inc. (TCDA) Insider Monkey
Dec-03-19 08:00AM  Tricida Announces Hiring of Elizabeth Faust, Ph.D., as Senior Vice President of Medical Affairs Business Wire
Nov-25-19 10:00AM  Tricida to Present at the Evercore Annual Global Healthcare Conference TEST Business Wire Releases
10:00AM  Tricida to Present at the Evercore Annual Global Healthcare Conference Business Wire
Nov-14-19 04:08PM  Tricida Announces Third Quarter 2019 Financial Results Business Wire
04:03PM  Tricida Announces FDA Acceptance of New Drug Application for Veverimer Business Wire
Nov-05-19 10:00AM  Tricida to Report Third Quarter Financial Results and Host Conference Call and Webcast on Thursday, November 14, 2019 Business Wire
Oct-25-19 10:12AM  Hedge Funds Have Never Been This Bullish On Tricida, Inc. (TCDA) Insider Monkey
Oct-04-19 10:24AM  Tricida to Host Investor Day on October 15, 2019 Business Wire
Oct-02-19 08:30AM  Tricida Announces Multiple Data Presentations on Metabolic Acidosis to be Given at ASN Kidney Week 2019 Business Wire
Sep-12-19 08:56AM  Tricida Launches Metabolic Acidosis Insights, an Online Educational Resource for the Healthcare Community Business Wire
Sep-04-19 08:30AM  Tricida Announces Submission of New Drug Application for Veverimer for the Treatment of Metabolic Acidosis in Patients with Chronic Kidney Disease Business Wire
Aug-10-19 12:09AM  Tricida, Inc. (TCDA) Q2 2019 Earnings Call Transcript Motley Fool
Aug-08-19 04:05PM  Tricida Announces Second Quarter 2019 Financial Results Business Wire
Aug-01-19 10:00AM  Tricida to Report Second Quarter Financial Results and Host Conference Call and Webcast on Thursday, August 8, 2019 Business Wire
Jun-27-19 07:33AM  Does Tricida's (NASDAQ:TCDA) Share Price Gain of 35% Match Its Business Performance? Simply Wall St. +8.99%
07:28AM  Should Tricida (NASDAQ:TCDA) Be Disappointed With Their 35% Profit? Simply Wall St.
Jun-25-19 09:01PM  Heres What Hedge Funds Think About Tricida, Inc. (TCDA) Insider Monkey
08:30AM  Tricida Announces Publication of Positive Long-Term Phase 3 Clinical Trial Results of Veverimer (TRC101) in The Lancet Business Wire
Jun-18-19 11:10AM  Zacks.com featured highlights include: Stifel, Napco, Tricida and Under Armour Zacks
Jun-17-19 08:32AM  4 Stocks Set to Pop on New Analyst Coverage Zacks +7.45%
Jun-05-19 10:00AM  Tricida to Present at the Goldman Sachs 40th Annual Global Healthcare Conference Business Wire
May-08-19 08:45PM  Tricida, Inc. (TCDA) Q1 2019 Earnings Call Transcript Motley Fool
04:05PM  Tricida Announces First Quarter 2019 Financial Results Business Wire
May-03-19 09:25AM  Did Hedge Funds Drop The Ball On Tricida, Inc. (TCDA) ? Insider Monkey
Apr-30-19 10:13AM  Tricida to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast on Wednesday, May 8, 2019 Business Wire
Apr-23-19 12:29PM  What Kind Of Shareholder Owns Most Tricida, Inc. (NASDAQ:TCDA) Stock? Simply Wall St.
Apr-08-19 05:03PM  Here's What Drove Tricida 67% Higher in March Motley Fool
04:05PM  Tricida Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire
Apr-04-19 09:57AM  The Zacks Analyst Blog Highlights: Alpine, Actinium, Molecular Templates, Tricida and Otonomy Zacks
Apr-03-19 08:07PM  Tricida Announces Pricing of Public Offering of Common Stock Business Wire
09:16AM  Small Drugmakers Outperforming the Bigshots: 7 Stocks to Buy Zacks
Apr-01-19 04:39PM  Why MAG Silver, comScore, and Tricida Slumped Today Motley Fool -8.52%
04:36PM  Tricida Announces Proposed Public Offering of Common Stock Business Wire
05:34AM  Will Tricida Continue to Surge Higher? Zacks
Mar-28-19 04:37PM  Tricida Surges on Positive Results of Chronic Kidney Disease Treatment TheStreet.com +57.04%
03:57PM  Here's Why Tricida's Soaring Today Motley Fool
11:33AM  Tricida Inc (TCDA) Q4 2018 Earnings Conference Call Transcript Motley Fool
07:15AM  Tricida Announces Positive Results From Long-Term Clinical Trial of TRC101 in Patients With CKD and Metabolic Acidosis Business Wire
07:07AM  Tricida Announces $200 Million Debt Facility With Hercules Capital Business Wire
07:00AM  Tricida Announces Fourth Quarter and Full-Year 2018 Financial Results Business Wire
06:00AM  Tricida Inc to Host Earnings Call ACCESSWIRE
Mar-27-19 04:44PM  Tricida to Report Long-Term Clinical Trial Results for TRC101 in CKD Patients with Metabolic Acidosis and Host Conference Call and Webcast on Thursday, March 28, 2019 Business Wire
Mar-11-19 08:30AM  Tricida Announces Publication of Positive TRC101 Pivotal Trial Results in The Lancet Business Wire
Mar-07-19 10:00AM  Tricida to Report Fourth Quarter and Full-Year 2018 Financial Results and Host Conference Call and Webcast on Thursday, March 28, 2019 Business Wire
Feb-27-19 10:00AM  Tricida to Present at the Cowen and Company 39th Annual Health Care Conference Business Wire
Jan-17-19 08:30AM  Tricida Announces Hiring of Susannah Cantrell, Ph.D., as Chief Commercial Officer Business Wire -5.44%
Jan-02-19 02:00PM  Tricida to Present at the 37th Annual J. P. Morgan Healthcare Conference Business Wire
Dec-20-18 10:35PM  Tricida, Inc. (TCDA): Hedge Fund Sentiment Unchanged Insider Monkey -6.26%
Nov-08-18 04:05PM  Tricida Announces Third Quarter 2018 Financial Results Business Wire
Nov-01-18 10:00AM  Tricida to Report Third Quarter Financial Results and Host Conference Call and Webcast on Thursday, November 8, 2018 Business Wire
Oct-04-18 04:26PM  Tricida Announces Presentation of TRCA-301 Pivotal Trial Results at the American Society of Nephrology Kidney Week Meeting in San Diego, October 23 - 28 Business Wire
Aug-08-18 04:05PM  Tricida Announces Second Quarter 2018 Financial Results and Provides Update on Key Initiatives Business Wire
03:00PM  Tricida Inc to Host Earnings Call ACCESSWIRE
Aug-01-18 08:30AM  Tricida Announces Hiring of Dawn Parsell as Senior Vice President of Clinical Development Business Wire
Jul-31-18 05:43PM  Tricida to Report Second Quarter Financial Results and Host Conference Call and Webcast on Wednesday, August 8, 2018 Business Wire
Jul-23-18 04:27PM  Tricida Post-IPO Run-up Makes Goldman Wary Benzinga
Jul-18-18 08:01PM  [$$] Biotech IPO Boom Comes With Side Effects The Wall Street Journal
12:26PM  [$$] Biotech IPO Boom Comes With Side Effects The Wall Street Journal
Jul-02-18 04:05PM  Tricida Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire
07:30AM  [$$] Biotech Companies Continue IPO Hot Streak, But For How Long? The Wall Street Journal
Tricida, Inc., a pharmaceutical company, focuses on the development and commercialization of its drug candidate, TRC101, a non-absorbed, orally-administered polymer designed as a potential treatment for metabolic acidosis in patients with chronic kidney disease (CKD). It has completed a Phase 3, double-blind, placebo-controlled trial of TRC101 in patients with CKD and metabolic acidosis. Tricida, Inc. was founded in 2013 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KLAERNER GERRITPresident and CEOApr 06Sale24.224,00096,880559,321Apr 08 04:34 PM
KLAERNER GERRITPresident and CEOMar 16Sale23.914,00095,64041,323Mar 18 04:09 PM
Parker Geoffrey M.Chief Fin. Officer and EVPMar 10Buy29.465,000147,30055,000Mar 11 05:10 PM
HEJLEK EDWARD JEVP, General Counsel & Secy.Mar 02Option Exercise0.9610,0009,60028,953Mar 04 07:36 PM
Otto Dawn ParsellEVP, Clinical DevelopmentMar 02Option Exercise2.484,25010,5503,249Mar 04 07:38 PM
HEJLEK EDWARD JEVP, General Counsel & Secy.Mar 02Sale31.6610,000316,61619,153Mar 04 07:36 PM
KLAERNER GERRITPresident and CEOMar 02Sale31.534,000126,120563,321Mar 04 07:33 PM
Otto Dawn ParsellEVP, Clinical DevelopmentMar 02Sale31.844,250135,316255Mar 04 07:38 PM
KLAERNER GERRITPresident and CEOFeb 18Sale36.104,000144,40045,323Feb 20 04:42 PM
Stahl WilhelmChief Tech Officer & Sr. VPFeb 05Option Exercise1.6850084015,306Feb 06 05:07 PM
Stahl WilhelmChief Tech Officer & Sr. VPFeb 05Sale38.9150019,45514,806Feb 06 05:07 PM
HEJLEK EDWARD JSVP, General Counsel & Secy.Feb 03Option Exercise0.9610,0009,60027,022Feb 05 09:29 PM
Otto Dawn ParsellSr VP, Clinical DevelopmentFeb 03Option Exercise2.484,25010,5503,249Feb 05 09:31 PM
Otto Dawn ParsellSr VP, Clinical DevelopmentFeb 03Sale36.864,250156,668255Feb 05 09:31 PM
HEJLEK EDWARD JSVP, General Counsel & Secy.Feb 03Sale36.4210,000364,16919,153Feb 05 09:29 PM
KLAERNER GERRITPresident and CEOFeb 03Sale36.334,000145,330567,321Feb 05 09:27 PM
KLAERNER GERRITPresident and CEOJan 15Sale35.264,000141,04049,323Jan 16 06:06 PM
HEJLEK EDWARD JSVP, General Counsel & Secy.Jan 02Option Exercise0.9610,0009,60029,101Jan 06 04:33 PM
Otto Dawn ParsellSr VP, Clinical DevelopmentJan 02Option Exercise1.684,2507,1402,620Jan 06 04:35 PM
HEJLEK EDWARD JSVP, General Counsel & Secy.Jan 02Sale37.0210,000370,15119,153Jan 06 04:33 PM
Otto Dawn ParsellSr VP, Clinical DevelopmentJan 02Sale37.044,250157,421255Jan 06 04:35 PM
KLAERNER GERRITPresident and CEOJan 02Sale37.154,000148,607571,321Jan 03 04:38 PM
HEJLEK EDWARD JSVP, General Counsel & Secy.Dec 26Option Exercise0.964,2004,03219,082Dec 30 04:46 PM
Stahl WilhelmChief Tech Officer & Sr. VPDec 23Option Exercise1.663,0004,99217,756Dec 26 04:36 PM
Stahl WilhelmChief Tech Officer & Sr. VPDec 23Sale38.913,000116,73014,806Dec 26 04:36 PM
HEJLEK EDWARD JSVP, General Counsel & Secy.Dec 20Option Exercise0.9615,00014,40029,882Dec 23 05:26 PM
HEJLEK EDWARD JSVP, General Counsel & Secy.Dec 20Sale38.1715,000572,55014,882Dec 23 05:26 PM
KLAERNER GERRITPresident and CEODec 18Sale38.9131,7501,235,45753,323Dec 20 05:30 PM
Bonita David PDirectorDec 11Sale40.001,500,00060,000,0009,614,280Dec 12 05:23 PM
ORBIMED ADVISORS LLCDirectorDec 11Sale40.001,500,00060,000,0009,614,280Dec 12 05:20 PM
KLAERNER GERRITPresident and CEODec 11Sale43.507,572329,346575,321Dec 12 07:27 PM
KLAERNER GERRITPresident and CEODec 10Sale43.283,948170,869582,893Dec 11 08:34 PM
COUFAL SANDRA IDirectorDec 10Sale43.171,62069,9354,860Dec 12 07:31 PM
COUFAL SANDRA IDirectorDec 10Sale43.2871330,859216,939Dec 12 07:31 PM
KLAERNER GERRITPresident and CEODec 02Sale39.494,000157,960586,841Dec 03 04:27 PM
KLAERNER GERRITPresident and CEONov 29Sale39.802,00079,60085,073Dec 03 04:27 PM
KLAERNER GERRITPresident and CEONov 29Sale39.802,00079,600590,841Dec 03 04:27 PM
Otto Dawn ParsellSr VP, Clinical DevelopmentNov 26Option Exercise1.515,7468,6512,355Nov 27 04:34 PM
Otto Dawn ParsellSr VP, Clinical DevelopmentNov 26Sale39.605,746227,5490Nov 27 04:34 PM
Alpern Robert JDirectorNov 26Sale39.591,00039,590137,390Nov 27 04:26 PM
COUFAL SANDRA IDirectorNov 22Sale41.00180,8647,415,4322,773,350Nov 26 07:09 PM
Isern Brian M.possible member of 10% groupNov 22Sale41.00180,8647,415,4322,773,350Nov 26 05:50 PM
Isern Brian M.possible member of 10% groupNov 21Sale40.98190,6827,815,043777,411Nov 22 05:48 PM
COUFAL SANDRA IDirectorNov 21Sale40.98190,6827,815,043777,411Nov 22 08:30 PM
Stahl WilhelmChief Tech Officer & Sr. VPNov 20Option Exercise1.688141,36815,620Nov 21 07:13 PM
Alpern Robert JDirectorNov 20Sale40.652,43999,145138,390Nov 21 07:09 PM
Stahl WilhelmChief Tech Officer & Sr. VPNov 20Sale40.8181433,21914,806Nov 21 07:13 PM
COUFAL SANDRA IDirectorNov 20Sale39.99112,1054,483,1816,480Nov 22 08:30 PM
COUFAL SANDRA IDirectorNov 20Sale40.2171328,670217,652Nov 22 08:30 PM
Isern Brian M.possible member of 10% groupNov 20Sale39.99110,5854,422,016836,505Nov 22 05:48 PM
Parker Geoffrey M.Chief Fin. Officer and Sr. VPNov 19Buy34.7294532,81050,000Nov 19 04:51 PM
Parker Geoffrey M.Chief Fin. Officer and Sr. VPNov 18Buy34.2819,055653,20549,055Nov 19 04:51 PM
Stahl WilhelmChief Tech Officer & Sr. VPNov 12Option Exercise1.688361,40415,642Nov 14 06:52 PM
Alpern Robert JDirectorNov 12Sale39.921,15946,267140,829Nov 14 06:54 PM
Stahl WilhelmChief Tech Officer & Sr. VPNov 12Sale39.9783633,41514,806Nov 14 06:52 PM
Stahl WilhelmChief Tech Officer & Sr. VPNov 07Option Exercise1.682,9104,88917,716Nov 12 06:56 PM
Stahl WilhelmChief Tech Officer & Sr. VPNov 07Sale39.972,910116,31314,806Nov 12 06:56 PM
Alpern Robert JDirectorNov 07Sale39.933,953157,843141,988Nov 12 06:53 PM
COUFAL SANDRA IDirectorNov 07Sale40.021004,0028,000Nov 12 06:51 PM
open in yahoo | open in reuters | open in google